Intensive chemotherapy with idarubicin, cytarabine and G-CSF in elderly patients with acute myelogenous leukemia (AML)

被引：0
|
作者：
Chaibi, P [1 ]
Dombret, H [1 ]
Rousselot, P [1 ]
Gardin, C [1 ]
Glaisner, S [1 ]
Castaigne, S [1 ]
Degos, L [1 ]
机构：
[1] HOP ST LOUIS,SERV CLIN MALAD SANG,PARIS,FRANCE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：822 / 822
页数：1
相关论文
共 50 条
  • [21] Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia
    Yalman, N
    Sarper, N
    Devecioglu, Ö
    Anak, S
    Eryilmaz, E
    Can, M
    Yenilmez, H
    Agaoglu, L
    Gedikoglu, G
    TURKISH JOURNAL OF PEDIATRICS, 2000, 42 (03) : 198 - 204
  • [22] G-CSF Priming, Clofarabine and High Dose Cytarabine (GCLAC) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Storer, Barry E.
    Appelbaum, Frederick R.
    BLOOD, 2009, 114 (22) : 816 - 816
  • [23] INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) - EFFECT OF AGE ON SURVIVAL
    WEINER, RS
    ELFENBEIN, GJ
    VOGLER, WR
    RANEY, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 209 - 209
  • [24] INFECTION OF ELDERLY PATIENTS RECEIVING HIGH-DOSE CYTARABINE-BASED CHEMOTHERAPY FOR INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML)
    NEMUNAITIS, J
    MEYER, W
    NEMUNAITIS, J
    TAYLOR, E
    RILEY, C
    COOPER, B
    LEUKEMIA RESEARCH, 1994, 18 (08) : 649 - 650
  • [25] Autologous stem cell transplantation (APSCT) with G-CSF primed peripheral blood in acute myelogenous leukemia (AML)
    Rio, B
    Boccaccio, C
    Belhocine, R
    Perrot, JY
    Zittoun, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 344 - 344
  • [26] Molecular Response in Core Binding Factor Acute Myelogenous Leukemia with Fludarbine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin.
    Borthakur, Gautam
    Faderl, Stefan
    Verstovsek, Srdan
    Jones, Dan
    Estrov, Zeev
    O'Brien, Susan
    Bass, Joyce
    Kantarjian, Hagop
    BLOOD, 2008, 112 (11) : 676 - 676
  • [27] Clinical and Molecular Response in Core Binding Factor Acute Myelogenous Leukemia with Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin
    Borthakur, Gautam
    Faderl, Stefan
    Ver-stovsek, Srdan
    Jones, Dan
    Gandhi, Varsha
    Estrov, Zeev
    O'Brien, Susan
    Ravandi, Farhad
    Bass, Joyce
    Brandt, Mark
    Kantarjian, Hagop
    BLOOD, 2009, 114 (22) : 812 - 812
  • [28] Phase II dosing study of cytarabine chemotherapy in combination with cenersen (EL625) and idarubicin in refractory and relapsed acute myelogenous leukemia (AML)
    Alvarado, Y.
    Kantarjian, H.
    Freireich, E. J.
    Garcia-Manero, G.
    Ferrajoli, A.
    Koller, C.
    Estrov, Z.
    Kornblau, S.
    Laddie, N.
    Smith, L.
    Cortes, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] G-CSF after chemotherapy for acute myeloid leukemia (AML) - Interim analysis of a placebo controlled trial
    Link, H
    Wandt, H
    SchonrockNabulsi, P
    Ehninger, G
    Franke, A
    Gackle, R
    Geer, T
    Gramatzki, M
    Linkesch, W
    Lutz, D
    Niederwieser, D
    Nikiforakis, E
    Ohl, S
    Otremba, B
    Pittermann, E
    Schmidt, H
    Tischler, J
    Weiss, J
    Wilhelm, M
    Deutschmann, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 841 - 841
  • [30] G-CSF after chemotherapy for acute myeloid leukemia (AML) - Interim analysis of a placebo controlled trial
    Montillo, M
    Mirto, S
    Pinto, A
    Tedeschi, A
    Magrin, S
    Zagonel, V
    Leoni, P
    Caronia, F
    Cimino, R
    Ferrara, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 842 - 842
12345